D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Consumer Discretionary | 9.06% |
| 3 | Financials | 8.14% |
| 4 | Healthcare | 8% |
| 5 | Energy | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Sana Biotechnology
SANA
$882M
| $1.99M | ﹤0.01% |
240,549
-47,552
| -17% | -$384K |
|
3152
CALL
Marvell Technology
MRVL
$147B
| $1.99M | ﹤0.01% |
27,700
-131,400
| -83% | -$9.47M |
|
|
CREC
3153
DELISTED
Crescera Capital Acquisition Corp Class A Ordinary Shares
CREC
| $1.99M | ﹤0.01% |
+200,000
| New | +$1.97M |
|
3154
PUT
Brinker International
EAT
$8.82B
| $1.98M | ﹤0.01% |
52,000
+2,000
| +4% | +$74.8K |
|
|
HMA
3155
DELISTED
Heartland Media Acquisition Corp.
HMA
| $1.98M | ﹤0.01% |
+200,000
| New | +$1.98M |
|
|
TRTN
3156
DELISTED
Triton International Limited
TRTN
| $1.98M | ﹤0.01% |
+28,206
| New | +$1.82M |
|
3157
Cullen/Frost Bankers
CFR
$10.5B
| $1.98M | ﹤0.01% |
14,290
-9,034
| -39% | -$1.26M |
|
3158
Prudential Financial
PRU
$42.6B
| $1.98M | ﹤0.01% |
16,733
-67,283
| -80% | -$7.65M |
|
3159
Cardio Diagnostics
CDIO
$4.68M
| $1.98M | ﹤0.01% |
+6,668
| New | +$1.97M |
|
3160
Polaris
PII
$3.83B
| $1.97M | ﹤0.01% |
18,693
-15,203
| -45% | -$1.73M |
|
|
IVC
3161
DELISTED
Invacare Corporation
IVC
| $1.97M | ﹤0.01% |
1,394,763
-211,522
| -13% | -$452K |
|
3162
EyePoint Inc
EYPT
$999M
| $1.97M | ﹤0.01% |
161,719
-116,953
| -42% | -$1.28M |
|
3163
Petco
WOOF
$797M
| $1.96M | ﹤0.01% |
+100,363
| New | +$1.88M |
|
|
MRO
3164
CALL
DELISTED
Marathon Oil Corporation
MRO
| $1.96M | ﹤0.01% |
78,000
+24,600
| +46% | +$528K |
|
3165
PUT
Applovin
APP
$134B
| $1.96M | ﹤0.01% |
+35,500
| New | +$2.26M |
|
3166
CALL
Nokia
NOK
$46.9B
| $1.95M | ﹤0.01% |
357,800
-100
| -0% | -$554 |
|
3167
V2X
VVX
$2.7B
| $1.95M | ﹤0.01% |
54,449
-16,971
| -24% | -$725K |
|
|
ZIMV
3168
DELISTED
ZimVie
ZIMV
| $1.95M | ﹤0.01% |
+85,434
| New | +$2.01M |
|
|
HGEN
3169
DELISTED
HUMANIGEN, INC.
HGEN
| $1.95M | ﹤0.01% |
647,291
+194,208
| +43% | +$520K |
|
|
AUD
3170
DELISTED
Audacy, Inc.
AUD
| $1.95M | ﹤0.01% |
673,138
+123,435
| +22% | +$326K |
|
|
BAND
3171
PUT
Bandwidth Inc
BAND
$1.19B
| $1.94M | ﹤0.01% |
60,000
-40,900
| -41% | -$1.96M |
|
3172
Omega Healthcare
OHI
$15.3B
| $1.94M | ﹤0.01% |
62,359
-251,548
| -80% | -$7.42M |
|
|
THR
3173
DELISTED
Thermon Group Holdings
THR
| $1.94M | ﹤0.01% |
119,935
-58,411
| -33% | -$1.02M |
|
3174
CALL
Kadant
KAI
$3.58B
| $1.94M | ﹤0.01% |
10,000
| – | – |
|
3175
CALL
Fate Therapeutics
FATE
$275M
| $1.94M | ﹤0.01% |
+50,000
| New | +$1.94M |
|
Similar funds
D.E. Shaw & Co's Q1 2022 Portfolio in Review
As of Q1 2022, D.E. Shaw & Co held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
D.E. Shaw & Co withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Cenovus Energy worth $141M.
- D.E. Shaw & Co's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- D.E. Shaw & Co added most to Starbucks in Q1 2022, an estimated $384M increase.
- D.E. Shaw & Co's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- D.E. Shaw & Co's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- D.E. Shaw & Co opened 934 new positions and closed 805 in Q1 2022.
- D.E. Shaw & Co's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.